Columbia University - College of Physicians and Surgeons

Dept. of Medicine | Division of Nephrology | A-Z Index

Kiryluk Lab

What is MOHD?

The Multi-Omics for Health and Disease Consortium (MOHD) is a research initiative established by the National Institutes of Health (NIH) to advance the generation and analysis of multi-omics data for human health research. As one of the six disease study sites (DSS) of MOHD, Columbia University led by Dr. Krzysztof Kiryluk will establish a chronic kidney disease (CKD) DSS to evaluate if multi-omic approaches can improve precision medicine and promote CKD care.

Goals of MOHD at Columbia:

What is being looked at from the sample you provide?

In addition to using your samples for routine tests, doctors and scientists will use your samples for Multi-omics testing:

Multi-Omics Kidney

Please check the MOHD flyer: English Version; Spanish Version

What do I do once I've enrolled?

What happens to my samples?

The samples will go to the MOHD research sites where scientists will study them. Any extra tissue will be stored in a central location, to be shared only with other researchers. Important genomic results that could affect your treatment will be returned to you.

How does MOHD protect my data?

MOHD takes data security and privacy very seriously. We take many steps to keep your medical data safe at every stage of the study. Your personal information will never be shared. Only approved research teams can see your data and samples. Data that is shared will be anonymized.

For more information, please visit www.mohdconsortium.org/